SI1001783T1 - Zdravljenje diabetesa s tiazolidindionom, insulinskim sekretagogom in digvanidinom - Google Patents

Zdravljenje diabetesa s tiazolidindionom, insulinskim sekretagogom in digvanidinom

Info

Publication number
SI1001783T1
SI1001783T1 SI9830804T SI9830804T SI1001783T1 SI 1001783 T1 SI1001783 T1 SI 1001783T1 SI 9830804 T SI9830804 T SI 9830804T SI 9830804 T SI9830804 T SI 9830804T SI 1001783 T1 SI1001783 T1 SI 1001783T1
Authority
SI
Slovenia
Prior art keywords
diguanide
thiazolidinedione
diabetes
treatment
insulin secretagogue
Prior art date
Application number
SI9830804T
Other languages
English (en)
Inventor
Robin Edwin Buckingham
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SI1001783T1 publication Critical patent/SI1001783T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
SI9830804T 1997-07-18 1998-07-16 Zdravljenje diabetesa s tiazolidindionom, insulinskim sekretagogom in digvanidinom SI1001783T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9715295A GB9715295D0 (en) 1997-07-18 1997-07-18 Novel method of treatment
PCT/GB1998/002110 WO1999003477A1 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide

Publications (1)

Publication Number Publication Date
SI1001783T1 true SI1001783T1 (sl) 2006-02-28

Family

ID=10816167

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830804T SI1001783T1 (sl) 1997-07-18 1998-07-16 Zdravljenje diabetesa s tiazolidindionom, insulinskim sekretagogom in digvanidinom

Country Status (40)

Country Link
EP (1) EP1001783B1 (sl)
JP (2) JP2001510159A (sl)
KR (1) KR100671918B1 (sl)
CN (1) CN1264303A (sl)
AP (1) AP1352A (sl)
AR (1) AR016349A1 (sl)
AT (1) ATE305790T1 (sl)
AU (1) AU8448898A (sl)
BG (1) BG64785B1 (sl)
BR (1) BR9810445A (sl)
CA (1) CA2296653C (sl)
CO (1) CO4940420A1 (sl)
CY (1) CY1105254T1 (sl)
DE (1) DE69831808T2 (sl)
DK (1) DK1001783T3 (sl)
DZ (1) DZ2562A1 (sl)
EA (1) EA003021B1 (sl)
ES (1) ES2251093T3 (sl)
GB (1) GB9715295D0 (sl)
HK (1) HK1028550A1 (sl)
HU (1) HUP0003629A3 (sl)
ID (1) ID24211A (sl)
IL (1) IL134046A0 (sl)
IN (1) IN189275B (sl)
MA (1) MA24607A1 (sl)
MY (1) MY155219A (sl)
NO (1) NO325727B1 (sl)
NZ (2) NZ501164A (sl)
OA (1) OA11279A (sl)
PE (1) PE99599A1 (sl)
PL (2) PL198017B1 (sl)
SA (1) SA98190468B1 (sl)
SI (1) SI1001783T1 (sl)
SK (1) SK285484B6 (sl)
TR (1) TR200000134T2 (sl)
TW (1) TW505516B (sl)
UA (1) UA70303C2 (sl)
UY (1) UY25102A1 (sl)
WO (1) WO1999003477A1 (sl)
ZA (1) ZA986363B (sl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
SK287038B6 (sk) * 1998-11-12 2009-10-07 Smithkline Beecham Plc Farmaceutický prostriedok na postupné uvoľňovanie 5-[4-[2-(N- metyl-N-(2-pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-diónu a metformínu a spôsob jeho výroby
SE9902918D0 (sv) * 1999-08-13 1999-08-13 Pharmacia & Upjohn Ab Methods for identification of compounds stimulating insulin secretion
JP2003514011A (ja) * 1999-11-16 2003-04-15 スミスクライン ビーチャム パブリック リミテッド カンパニー チアゾリジンジオン−塩酸メトホルミンを含む医薬組成物
MY125516A (en) * 1999-11-16 2006-08-30 Smithkline Beecham Plc Novel composition based on thiazolidinedione and metformin and use
FR2812547B1 (fr) * 2000-08-04 2002-10-31 Lipha Composition pharmaceutique comprenant une association metformine et derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
US7964216B2 (en) 2001-01-12 2011-06-21 Sun Pharma Advanced Research Company Limited Spaced drug delivery system
ITFI20010126A1 (it) * 2001-07-09 2003-01-09 Molteni & C Composizioni farmaceutiche per uso orale,contenenti,in combinazione,metformina e gliclazide
MXPA04000180A (es) * 2001-07-10 2004-11-22 Kos Life Sciences Inc Formulacion de nucleo que comprende hidrocloruro de pioglitazona y una biguanida.
WO2003105809A1 (en) 2002-06-17 2003-12-24 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
UA80991C2 (en) 2002-10-07 2007-11-26 Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
NZ546337A (en) 2003-10-31 2009-03-31 Takeda Pharmaceutical Solid preparation comprising an insulin sensitizer such as pioglitazone hydrochloride, an insulin secretagogue such as glimepiride and a polyoxyethylene sorbitan fatty acid ester such as Polysorbate 80
MXPA05010977A (es) * 2005-10-12 2007-04-11 Abdala Leopoldo Espinosa Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus.
KR100812538B1 (ko) * 2006-10-23 2008-03-11 한올제약주식회사 약물 제어방출형 메트포르민-글리메피리드 복합제제
CN101417130B (zh) * 2007-10-22 2010-10-06 鲁南制药集团股份有限公司 一种治疗ⅱ型糖尿病及其并发症的药物组合物
JP7005050B2 (ja) 2017-10-20 2022-01-21 ノブメタファーマ カンパニー リミテッド 亜鉛塩、シクロ-ヒスプロおよび抗糖尿薬物を有効成分として含有する糖尿病の予防または治療用薬学的組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物,其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
US5061717A (en) * 1988-03-08 1991-10-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents
WO1989008651A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−2,4−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
DK0601001T3 (da) * 1991-08-26 1997-10-20 Upjohn Co Flydende næringsmiddelprodukt indeholdende 3-guanidinopropionsyre.
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TWI238064B (en) * 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
EA003025B1 (ru) * 1997-06-18 2002-12-26 Смитклайн Бичам Плс Лечение диабета тиазолидиндионом и сульфонилмочевиной

Also Published As

Publication number Publication date
TW505516B (en) 2002-10-11
DZ2562A1 (fr) 2003-02-15
CN1264303A (zh) 2000-08-23
MA24607A1 (fr) 1999-04-01
EA200000139A1 (ru) 2000-06-26
CA2296653A1 (en) 1999-01-28
JP2001510159A (ja) 2001-07-31
HK1028550A1 (en) 2001-02-23
AR016349A1 (es) 2001-07-04
CY1105254T1 (el) 2010-03-03
HUP0003629A3 (en) 2003-04-28
IL134046A0 (en) 2001-04-30
ATE305790T1 (de) 2005-10-15
DK1001783T3 (da) 2006-02-06
UA70303C2 (uk) 2004-10-15
ID24211A (id) 2000-07-13
SA98190468B1 (ar) 2007-01-20
EA003021B1 (ru) 2002-12-26
PL338126A1 (en) 2000-09-25
SK592000A3 (en) 2000-09-12
KR100671918B1 (ko) 2007-01-22
EP1001783A1 (en) 2000-05-24
JP2005213273A (ja) 2005-08-11
NZ511608A (en) 2002-12-20
KR20010021947A (ko) 2001-03-15
HUP0003629A2 (hu) 2001-07-30
GB9715295D0 (en) 1997-09-24
ES2251093T3 (es) 2006-04-16
NO20000228L (no) 2000-01-17
AP2000001733A0 (en) 2000-03-31
AP1352A (en) 2004-12-24
DE69831808T2 (de) 2006-07-06
TR200000134T2 (tr) 2000-09-21
NO20000228D0 (no) 2000-01-17
NO325727B1 (no) 2008-07-07
SK285484B6 (sk) 2007-02-01
CA2296653C (en) 2007-10-02
BG104135A (en) 2000-10-31
EP1001783B1 (en) 2005-10-05
BR9810445A (pt) 2000-09-05
DE69831808D1 (de) 2006-02-16
WO1999003477A1 (en) 1999-01-28
ZA986363B (en) 2000-01-17
BG64785B1 (bg) 2006-04-28
PL197844B1 (pl) 2008-05-30
PL198017B1 (pl) 2008-05-30
PE99599A1 (es) 1999-12-18
AU8448898A (en) 1999-02-10
NZ501164A (en) 2001-06-29
IN189275B (sl) 2003-01-25
UY25102A1 (es) 2000-12-29
CO4940420A1 (es) 2000-07-24
OA11279A (en) 2003-07-31
MY155219A (en) 2015-09-30

Similar Documents

Publication Publication Date Title
AP9901719A0 (en) Treatment of diabetes with thiazolidinedione and metormin
IL134046A0 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
HK1045111A1 (en) (3-Trihalomethylphenoxy) (4-halophenyl) for the treatment of insulin reisistance and type 2 diabetes
PL342517A1 (en) Methods of treating diabetes employing peptidic insulin analoques
ZA985546B (en) Treatment of insulin resistance.
PL343123A1 (en) Treatment of diabetes with rosiglitazone and insulin
IL133907A0 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
AP2000001734A0 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
IL133137A0 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
HUP0002668A3 (en) Treatment of diabetes with thiazolidinedione and metformin
HUP0002669A3 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
IL94241A0 (en) Diagnosis and treatment of insulin dependent diabetes mellitus
AU8884198A (en) Diagnosis, prevention and treatment of diabetes
IL119526A0 (en) Preparations comprising T cells for prevention or treatment of insulin dependent diabetes mellitus (IDDM)